Patient-Centered Approaches to Clinical Research in Oncology

04/20/2021 By Andrea

Article contributed to PharmaLeaders by Edward F. Ikeguchi, M.D., the Chief Executive Officer at AiCure Most of us have personal experiences with cancer, whether ourselves or with loved ones. We know that cancer is frightening and that treatment regimens can be stressful, exhausting and overwhelming. Patients participating in drug trials for oncology are subject to […]

This is how XR technology is transforming medical device training

02/17/2021 By Andrea

Article contributed and authored by: Dr. Alex Young, NHS surgeon and founder of Virti It’s estimated by the World Health Organisation (WHO) that there are more than 2 million different kinds of medical devices in the global market, ranging from surgical instruments to wound care apparatus and diagnostic software. Without them, modern medical practice as […]

ViiV begins rolling submission for cabotegravir to prevent HIV in US

05/05/2021

ViiV Healthcare has initiated a rolling submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for long-acting cabotegravir to prevent human immunodeficiency The post ViiV begins rolling submission for cabotegravir to prevent HIV in US appeared first on … [Read More...]

Revive Therapeutics, UCSF partner to study Bucillamine for severe Covid-19

05/04/2021

Specialty life sciences company Revive Therapeutics has signed a research agreement with University of California, San Francisco (UCSF) to study Bucillamine as a potential treatment for severe Covid-19. The post Revive Therapeutics, UCSF partner to study Bucillamine for severe Covid-19 appeared … [Read More...]

WHO grants emergency use listing for Moderna’s Covid-19 vaccine

05/03/2021

World Health Organization (WHO) has granted emergency use listing (EUL) for Moderna’s Covid-19 vaccine to prevent the infection in people aged 18 years and above. The Covid-19 Vaccine The post WHO grants emergency use listing for Moderna’s Covid-19 vaccine appeared first on … [Read More...]

CANbridge signs license agreement with Mirum for maralixibat in Greater China

04/30/2021

Biopharmaceutical company CANbridge Pharmaceuticals has signed a licensing agreement with Mirum Pharmaceuticals for the development and commercialisation of maralixibat in Greater China. Maralixibat is a minimally absorbed, orally The post CANbridge signs license agreement with Mirum for … [Read More...]

Featured Article

Patient-Centered Approaches to Clinical Research in Oncology

This is how XR technology is transforming medical device training

White Papers

GSK’s New “Ethical” Customer Approach: Is it Delivering?

Fix Your Marketing Funnel

Industry News

ViiV begins rolling submission for cabotegravir to prevent HIV in US

Revive Therapeutics, UCSF partner to study Bucillamine for severe Covid-19

WHO grants emergency use listing for Moderna’s Covid-19 vaccine

CANbridge signs license agreement with Mirum for maralixibat in Greater China